The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Clinical trial NCT04630964 · COMPLETED
Trial details
- NCT number
- NCT04630964
- Sponsor
- Section for Affective Disorders; Northern Stockholm Psychiatry
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2023-04-19
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.